Development of (225)Ac Production from Low Isotopic Dilution (229)Th

[Image: see text] The promise of (225)Ac targeted alpha therapies has been on the horizon for the last two decades. TerraPower Isotopes are uniquely suited to produce clinically relevant quantities of (225)Ac through the decay of (229)Th. Herein, a rapid processing scheme to isolate radionuclidic an...

Descripción completa

Detalles Bibliográficos
Autores principales: Camacaro, Jose F., Dunckley, Christopher P., Harman, S. Elizabeth, Fitzgerald, Hilary A., Lakes, Andrew L., Liao, Zuolei, Ludwig, Russell C., McBride, Katie M., Yalcintas Bethune, Ezgi, Younes, Ali, Chatterjee, Sayandev, Lilley, Laura M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601055/
https://www.ncbi.nlm.nih.gov/pubmed/37901510
http://dx.doi.org/10.1021/acsomega.3c01769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601055/
https://www.ncbi.nlm.nih.gov/pubmed/37901510
http://dx.doi.org/10.1021/acsomega.3c01769

Ejemplares similares